These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25256433)

  • 21. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
    Keskar V; Sood MM
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2085-2092. PubMed ID: 27797891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].
    Schlieper G; Schwenger V; Remppis A; Keller T; Dechend R; Massberg S; Baldus S; Weinreich T; Hetzel G; Floege J; Mahfoud F; Fliser D
    Internist (Berl); 2017 May; 58(5):512-521. PubMed ID: 28396914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [NOACs and Chronic kidney disease].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):188-204. PubMed ID: 28682039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Qamar A; Bhatt DL
    Circulation; 2016 Apr; 133(15):1512-5. PubMed ID: 27067086
    [No Abstract]   [Full Text] [Related]  

  • 26. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Le D; Morelli R; Badhwar N; Lee RJ
    Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left atrial appendage closure.
    Lin AC; Knight BP
    Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Another novel oral anticoagulant matches warfarin.
    Mitka M
    JAMA; 2014 Jan; 311(3):233-4. PubMed ID: 24430308
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines.
    Młodawska E; Tomaszuk-Kazberuk A; Łopatowska P; Musiał WJ; Małyszko J
    Pol Arch Med Wewn; 2016 May; 126(5):353-62. PubMed ID: 27243343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ineligibility for anticoagulation in patients with atrial fibrillation.
    del Conde I; Halperin JL
    Am J Med; 2013 Feb; 126(2):105-11. PubMed ID: 23331435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease.
    Schwartzenberg S; Lev EI; Sagie A; Korzets A; Kornowski R
    Am J Cardiol; 2016 Feb; 117(3):477-82. PubMed ID: 26721651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
    Wong CW
    Hong Kong Med J; 2016 Dec; 22(6):608-15. PubMed ID: 27920399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Improvements in oral anticoagulant therapy for atrial fibrillation].
    Briongos Figuero S; García Santos-Gallego C; Badimón JJ
    Med Clin (Barc); 2013 Dec; 141(11):487-93. PubMed ID: 23597953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct Oral Anticoagulants in Advanced Chronic Kidney Disease: Evaluating the Evidence in Atrial Fibrillation.
    Messerschmidt K
    S D Med; 2018 Nov; 71(11):518-520. PubMed ID: 30742754
    [No Abstract]   [Full Text] [Related]  

  • 36. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticoagulation in polypathological patients with atrial fibrillation].
    Díez-Manglano J; Bernabeu-Wittel M; Barón-Franco B; Murcia-Zaragoza J; Fuertes Martín A; Alemán A; Ollero-Baturone M;
    Med Clin (Barc); 2013 Feb; 140(3):97-103. PubMed ID: 23199837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.